AVNT AVIENT CORP

NYSE Plastic Materials, Synth Resins & Nonvulcan Elastomers CIK: 0001122976
AI RATING
STRONG_SELL
85% Confidence

Investment Thesis

Avient demonstrates severely deteriorating fundamental health despite extreme revenue growth, evidenced by persistent negative operating cash flow (-$34.5M) and negative free cash flow (-$53.5M) that is burning down cash reserves unsustainably. The 6941.5% YoY revenue growth coupled with declining net income (-2.0% YoY) and sharply lower EPS (-51.6% YoY) indicates poor quality earnings likely from problematic acquisition integration. The combination of weak capital returns (ROE 2.3%, ROA 0.9%), minimal interest coverage (1.6x), and cash burn creates acute financial distress.

Strengths

  • + Adequate liquidity buffer of $427.6M in cash and equivalents
  • + Moderate leverage with 0.80x debt-to-equity ratio
  • + Positive gross margin (32.2%) and operating margin (11.3%) indicate underlying business profitability

Risks

  • ! Critical negative operating cash flow of -$34.5M indicates unsustainable business model despite accounting profits
  • ! Negative free cash flow of -$53.5M actively depleting cash reserves with no viable turnaround evident
  • ! Extreme revenue growth (6941.5% YoY) with simultaneous earnings decline signals acquisition-driven distress and poor integration
  • ! Dangerously low interest coverage of 1.6x leaves minimal buffer for revenue decline or economic downturn
  • ! Severely depressed returns on capital (ROE 2.3%, ROA 0.9%) indicate capital destruction
  • ! 30 insider Form 4 filings in 90 days suggest executive concern or distressed activity

Key Metrics to Watch

Financial Metrics

Revenue
847.4M
Net Income
55.7M
EPS (Diluted)
$0.61
Free Cash Flow
-53.5M
Total Assets
5.9B
Cash
427.6M

Profitability Ratios

Gross Margin 32.2%
Operating Margin 11.3%
Net Margin 6.6%
ROE 2.3%
ROA 0.9%
FCF Margin -6.3%

Balance Sheet & Liquidity

Current Ratio
1.77x
Quick Ratio
1.29x
Debt/Equity
0.80x
Debt/Assets
20.0%
Interest Coverage
1.58x
Long-term Debt
1.9B
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-05-09T09:39:11.116262 | Data as of: 2026-03-31 | Powered by Claude AI